Search Within

Dmitriy Zamarin

  1. "Melanoma and Immunotherapeutics Service"
Formats
  1. Journal Article (26)
  2. Meeting Abstract (17)
  3. Guidelines (2)
  4. Book Section (1)
Groups
  1. Department of Medicine (46)
  2. GDMT, Medicine (46)
  3. Gynecologic Medicine Service (46)
  4. Gynecology Disease Management Team (46)
  5. Melanoma and Immunotherapeutics Service (46)
  6. Solid Tumor Oncology Division (46)

More Groups

People
  1. Jedd Wolchok (34)
  2. Taha Merghoub (33)
  3. Jacob Ricca (12)
  4. Rikke Holmgaard (12)
  5. Mathieu Gigoux (8)
  6. Cailian Liu (7)

More People

Years
  1. 2023 (2)
  2. 2022 (4)
  3. 2021 (3)
  4. 2020 (7)
  5. 2019 (3)
  6. 2018 (5)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (10)
  2. Gynecologic Oncology (4)
  3. Cancer Immunology Research (3)
  4. Cell (3)
  5. JCO Precision Oncology (2)
  6. JNCI: Journal of the National Cancer Institute (2)

More Publications

Publishers
  1. Biomed Central Ltd (10)
  2. Elsevier Inc. (6)
  3. American Association for Cancer Research (5)
  4. Cell Press (5)
  5. Nature Publishing Group (4)
  6. American Society of Clinical Oncology (3)

More Publishers

Results (46)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pre-existing immunity to oncolytic virus potentiates its therapeutic efficacy
    Meeting Abstract

    Ricca, J.; Merghoub, T.; Wolchok, J. D.; Zamarin, D.
    Journal for ImmunoTherapy of Cancer (2016)

    Fulltext@MSK | Save
  • Heat-inactivated modified vaccinia virus Ankara induces type I IFN and antitumor immunity via the cytosolic DNA-sensing pathway
    Meeting Abstract

    Dai, P. H.; Wang, W. Y.; Serna-Tamayo, C.; Zamarin, D.; Shuman, S.; Merghoub, T.; Wolchok, J. D.; Deng, L.
    Cancer Immunology Research (2016)

    Fulltext@MSK | Save
  • Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors
    Journal Article

    Holmgaard, R. B.; Zamarin, D.; Lesokhin, A.; Merghoub, T.; Wolchok, J. D.
    EBioMedicine (2016)

    Fulltext@MSK | Save
  • Immunotherapy of melanoma
    Journal Article

    Snyder, A.; Zamarin, D.; Wolchok, J. D.
    Progress in Tumor Research (2015)

    Fulltext@MSK | Save
  • The new era of cancer immunotherapy: Manipulating T-cell activity to overcome malignancy
    Journal Article

    Khalil, D. N.; Budhu, S.; Gasmi, B.; Zappasodi, R.; Hirschhorn-Cymerman, D.; Plitt, T.; De Henau, O.; Zamarin, D.; Holmgaard, R. B.; Murphy, J. T.; more...
    Advances in Cancer Research (2015)

    Fulltext@MSK | Save
  • Tumor-expressed IDO recruits and activates MDSCs in a Treg-dependent manner
    Journal Article

    Holmgaard, R. B.; Zamarin, D.; Li, Y.; Gasmi, B.; Munn, D. H.; Allison, J. P.; Merghoub, T.; Wolchok, J. D.
    Cell Reports (2015)

    Fulltext@MSK | Save
  • Immune checkpoint modulation: Rational design of combination strategies
    Journal Article

    Zamarin, D.; Postow, M. A.
    Pharmacology & Therapeutics (2015)

    Fulltext@MSK | Save
  • Expression of indoleamine 2.3-dioxygenase by tumors induces local and systemic immunosuppressive effects in a murine melanoma model
    Meeting Abstract

    Holmgaard, R. B.; Zamarin, D.; Munn, D. H.; Merghoub, T.; Wolchok, J. D.
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save
  • Potentiation of immunomodulatory antibodies with oncolytic viruses for therapy of poorlyimmunogenic tumors
    Meeting Abstract

    Zamarin, D.; Holmgaard, R. B.; Plitt, T.; Allison, J.; Merghoub, T.; Wolchok, J. D.
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save
  • Potentiation of immune checkpoint blockade cancer immunotherapy with oncolytic virus
    Meeting Abstract

    Zamarin, D.; Holmgaard, R. B.; Subudhi, S. K.; Park, J. S.; Mansour, M.; Palese, P.; Merghoub, T.; Wolchok, J. D.; Allison, J. P.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save